Factors influencing acceptance of RSV immunization for newborns among pregnant individuals: A mixed-methods study

Dominique Gagnon1, Charlotte Gubany2, Manale Ouakki1

  • 1Direction des risques biologiques, Institut national de santé publique du Québec, 945 Av. Wolfe, Québec (Québec), G1V 5B3, Canada.

Vaccine
|March 29, 2025
PubMed

Insights

Pregnant individuals show high interest in new respiratory syncytial virus (RSV) immunizations for infants. Key factors for acceptance include vaccine safety, efficacy, and healthcare provider recommendations, crucial for preventing infant hospitalizations.

Area of Science:

  • Public Health
  • Immunology
  • Maternal-Fetal Medicine

Background:

  • Respiratory syncytial virus (RSV) is a significant cause of infant respiratory illness and hospitalization in Canada.
  • Health Canada has approved two new preventative measures: a maternal vaccine and an infant monoclonal antibody.
  • Understanding pregnant individuals' perspectives on these novel RSV prevention methods is essential.

Purpose of the Study:

  • To assess knowledge, attitudes, and intentions of pregnant individuals regarding RSV and its prevention.
  • To explore decision-making factors and preferences for maternal vaccination versus infant monoclonal antibodies.
  • To identify barriers and facilitators for uptake of new RSV immunizing products.

Main Methods:

  • A mixed-methods study conducted in Quebec, Canada (October-December 2023).
  • Online survey (n=803) assessing RSV knowledge, attitudes, and intentions towards immunization products.
  • Qualitative interviews (n=25) exploring decision-making factors and preferences for RSV prevention.

Main Results:

  • High intention for both RSV maternal vaccination (88.1%) and infant monoclonal antibodies (92%).
  • Majority preferred maternal vaccination (69%) over infant antibodies.
  • Key acceptance factors included infant protection, product safety, efficacy, and healthcare provider recommendations; safety concerns were also noted.

Conclusions:

  • Pregnant individuals express strong interest in both maternal vaccination and infant monoclonal antibodies for RSV prevention.
  • Healthcare provider recommendations and clear information on safety and efficacy are critical for successful implementation.
  • Bridging the gap between intention and action requires addressing parental concerns and providing evidence-based guidance.
Abstract

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...